(Q69895070)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2881156%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

Timing of levodopa therapy: evidence from MPTP-treated primates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2881156%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

author name string

C E Clarke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2881156%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

S Boyce

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2881156%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

M A Sambrook

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2881156%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

A R Crossman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2881156%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

language of work or name

English

0 references

publication date

1 March 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2881156%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2881156%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2881156%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

8533

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2881156%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

625

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2881156%20AND%20SRC:MED&resulttype=core&format=json

Chronic low-dose levodopa therapy in Parkinson's disease: an argument for delaying levodopa therapy

6 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2990260-1

7 January 2021

Rationale for early use of levodopa in parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2990260-1

7 January 2021

When should levodopa be started?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2990260-1

7 January 2021

Evidence to support early levodopa therapy in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2990260-1

7 January 2021

Long-term follow-up of early dopa treatment in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2990260-1

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2990260-1

7 January 2021

Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2990260-1

7 January 2021

Saccade responses to dopamine in human MPTP-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2990260-1

7 January 2021

10.1016/S0140-6736(87)90260-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2881156%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference